Clinical Trial Update: Intermittent Intravenous Levosimendan in Ambulatory Advanced Chronic Heart Failure Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing intermittent intravenous levosimendan in ambulatory patients with advanced chronic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Simdax (levosimendan)

Snippet

Sponsor: Parc de Salut Mar | Conditions: Heart Failure | Phase 4 | Status: COMPLETED